Thermo Fisher Scientific Inc. (TMO)

NYSE · Healthcare · Diagnostics & Research
$669.54-2.79%As of 2026-11-22 · USD
Last session low $667.95Last session high $692.00
52-week low $435.2752-week high $727.56
Market cap
$248.08B
Sector
Healthcare
P/E (TTM)
35.3x
Dividend yield
0.28%
Next earnings
2027-01-28 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)45.5In the neutral range (30 to 70)
MACD (12, 26, 9)3.51Below its signal line (7.70); histogram -4.19
Bollinger %B (20, 2)-5%Below the lower band (671.89 to 722.24)
SMA 20697.06Price is 3.9% below
SMA 50678.65Price is 1.3% below
SMA 200558.09Price is 20.0% above
ATR (20)2.80% of priceAverage true range per day
52-week position80%In the upper part of the 435.27 to 727.56 range

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.

Insider filings, 90 daysNo purchases and 2 sales (about $4.5M).
Latest fiscal yearEnded 2025-12-31: revenue of $44.56B and an operating margin of 18.2%.
Next earnings reportExpected on 2027-01-28 (the date is an estimate).

More in Diagnostics & Research